These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9239764)

  • 1. Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders.
    Fredman P; Lekman A
    Neurochem Res; 1997 Aug; 22(8):1071-83. PubMed ID: 9239764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glycosphingolipids in neurological disorders. Mechanisms of immune action.
    Yu RK; Ariga T
    Ann N Y Acad Sci; 1998 Jun; 845():285-306. PubMed ID: 9668363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosphingolipids in the cerebrospinal fluid of patients with multiple sclerosis.
    Miyatani N; Saito M; Ariga T; Yoshino H; Yu RK
    Mol Chem Neuropathol; 1990 Dec; 13(3):205-16. PubMed ID: 2099783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders.
    Galban-Horcajo F; Halstead SK; McGonigal R; Willison HJ
    Curr Opin Chem Biol; 2014 Feb; 18():78-86. PubMed ID: 24495749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiganglioside antibodies in neurological diseases.
    Wanleenuwat P; Iwanowski P; Kozubski W
    J Neurol Sci; 2020 Jan; 408():116576. PubMed ID: 31726381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosphingolipid antibodies in serum in patients with sciatica.
    Brisby H; Balagué F; Schafer D; Sheikhzadeh A; Lekman A; Nordin M; Rydevik B; Fredman P
    Spine (Phila Pa 1976); 2002 Feb; 27(4):380-6. PubMed ID: 11840104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Antibodies to Glycans in Peripheral Neuropathies.
    Sonnino S; Chiricozzi E; Ciampa MG; Mauri L; Prinetti A; Toffano G; Aureli M
    Mol Neurobiol; 2017 Mar; 54(2):1564-1567. PubMed ID: 26867654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.
    Schirmer L; Worthington V; Solloch U; Loleit V; Grummel V; Lakdawala N; Grant D; Wassmuth R; Schmidt AH; Gebhardt F; Andlauer TF; Sauter J; Berthele A; Lunn MP; Hemmer B
    J Neurol; 2016 Oct; 263(10):2105-13. PubMed ID: 27485170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy.
    Kanda T; Yamawaki M; Iwasaki T; Mizusawa H
    Neurology; 2000 Apr; 54(7):1459-64. PubMed ID: 10751258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Glycosphingolipids in health and disease.
    Zhang X; Kiechle FL
    Ann Clin Lab Sci; 2004; 34(1):3-13. PubMed ID: 15038664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of autoantibodies in neurological diseases].
    Tanaka K
    Rinsho Shinkeigaku; 2004 Nov; 44(11):935-7. PubMed ID: 15651336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors.
    Ariga T; Suetake K; Nakane M; Kubota M; Usuki S; Kawashima I; Yu RK
    Neurosignals; 2008; 16(2-3):226-34. PubMed ID: 18253060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antiglycolipid antibodies in neurological disorders.
    Fredman P
    Ann N Y Acad Sci; 1998 Jun; 845():341-52. PubMed ID: 9668367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, organization, and function of glycosphingolipids in membrane.
    Hakomori S
    Curr Opin Hematol; 2003 Jan; 10(1):16-24. PubMed ID: 12483107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modulators of glycosphingolipid biosynthesis (PDMP): application to cell biology].
    Inokuchi J
    Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2495-502. PubMed ID: 9883678
    [No Abstract]   [Full Text] [Related]  

  • 18. Gangliosides and Autoimmune Peripheral Nerve Diseases.
    Goodfellow JA; Willison HJ
    Prog Mol Biol Transl Sci; 2018; 156():355-382. PubMed ID: 29747820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glycosphingolipid autoantibodies in rheumatologic disorders.
    Zeballos RS; Fox RI; Cheresh DA; McPherson RA
    J Clin Lab Anal; 1994; 8(6):378-84. PubMed ID: 7869176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.